Rg1 acts on neurological diseases through a variety of signal pathways and related molecular mechanisms in conditions such as PD, AD, HD, stroke, cerebral infarction, ischemia-reperfusion injury, depression, and stress. This evidence concerns the gene PPP1R3A and depressive symptom measurement.